BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24569369)

  • 1. Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.
    Limpert AS; Cosford ND
    J Clin Invest; 2014 Mar; 124(3):964-7. PubMed ID: 24569369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.
    Kong Q; Chang LC; Takahashi K; Liu Q; Schulte DA; Lai L; Ibabao B; Lin Y; Stouffer N; Das Mukhopadhyay C; Xing X; Seyb KI; Cuny GD; Glicksman MA; Lin CL
    J Clin Invest; 2014 Mar; 124(3):1255-67. PubMed ID: 24569372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity.
    Colton CK; Kong Q; Lai L; Zhu MX; Seyb KI; Cuny GD; Xian J; Glicksman MA; Lin CL
    J Biomol Screen; 2010 Jul; 15(6):653-62. PubMed ID: 20508255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.
    Kim K; Lee SG; Kegelman TP; Su ZZ; Das SK; Dash R; Dasgupta S; Barral PM; Hedvat M; Diaz P; Reed JC; Stebbins JL; Pellecchia M; Sarkar D; Fisher PB
    J Cell Physiol; 2011 Oct; 226(10):2484-93. PubMed ID: 21792905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridazine-derivatives Enhance Structural and Functional Plasticity of Tripartite Synapse Via Activation of Local Translation in Astrocytic Processes.
    Foster JB; Zhao F; Wang X; Xu Z; Lin K; Askwith CC; Hodgetts KJ; Lin CG
    Neuroscience; 2018 Sep; 388():224-238. PubMed ID: 30056115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model.
    Falcucci RM; Wertz R; Green JL; Meucci O; Salvino J; Fontana ACK
    ACS Chem Neurosci; 2019 Aug; 10(8):3437-3453. PubMed ID: 31257852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of astrocyte excitatory amino acid transporter 2 alleviates central sensitization in a rat model of chronic migraine.
    Zhou X; Liang J; Wang J; Fei Z; Qin G; Zhang D; Zhou J; Chen L
    J Neurochem; 2020 Nov; 155(4):370-389. PubMed ID: 31872442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease.
    Takahashi K; Kong Q; Lin Y; Stouffer N; Schulte DA; Lai L; Liu Q; Chang LC; Dominguez S; Xing X; Cuny GD; Hodgetts KJ; Glicksman MA; Lin CL
    J Exp Med; 2015 Mar; 212(3):319-32. PubMed ID: 25711212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.
    Karki P; Smith K; Johnson J; Aschner M; Lee EY
    Neurochem Res; 2015 Feb; 40(2):380-8. PubMed ID: 25064045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators.
    Chelini A; Brogi S; Paolino M; Di Capua A; Cappelli A; Giorgi G; Farzad M; Di Cesare Mannelli L; Micheli L; Ghelardini C; Anzini M
    J Med Chem; 2017 Jun; 60(12):5216-5221. PubMed ID: 28525717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization.
    Foran E; Rosenblum L; Bogush A; Pasinelli P; Trotti D
    Glia; 2014 Aug; 62(8):1241-53. PubMed ID: 24753081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.
    Lee SG; Su ZZ; Emdad L; Gupta P; Sarkar D; Borjabad A; Volsky DJ; Fisher PB
    J Biol Chem; 2008 May; 283(19):13116-23. PubMed ID: 18326497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS.
    Rosenblum LT; Shamamandri-Markandaiah S; Ghosh B; Foran E; Lepore AC; Pasinelli P; Trotti D
    Exp Neurol; 2017 Jun; 292():145-153. PubMed ID: 28342750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational control of glial glutamate transporter EAAT2 expression.
    Tian G; Lai L; Guo H; Lin Y; Butchbach ME; Chang Y; Lin CL
    J Biol Chem; 2007 Jan; 282(3):1727-37. PubMed ID: 17138558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.
    Green JL; Dos Santos WF; Fontana ACK
    Biochem Pharmacol; 2021 Nov; 193():114786. PubMed ID: 34571003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.
    Li Y; Sattler R; Yang EJ; Nunes A; Ayukawa Y; Akhtar S; Ji G; Zhang PW; Rothstein JD
    Neuropharmacology; 2011 Jun; 60(7-8):1168-75. PubMed ID: 21034752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line.
    Legay V; Deleage C; Beaulieux F; Giraudon P; Aymard M; Lina B
    Eur J Neurosci; 2003 May; 17(9):1820-8. PubMed ID: 12752781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis.
    Lin CL; Bristol LA; Jin L; Dykes-Hoberg M; Crawford T; Clawson L; Rothstein JD
    Neuron; 1998 Mar; 20(3):589-602. PubMed ID: 9539131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases.
    Fontana IC; Souza DG; Souza DO; Gee A; Zimmer ER; Bongarzone S
    J Med Chem; 2023 Feb; 66(4):2330-2346. PubMed ID: 36787643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.